Clinical Trial Results:
A Multicenter, Double-Blind, Flexible-Dose, 6-Month Trial Comparing the Efficacy and Safety of Asenapine With Olanzapine in Stable Subjects With Predominant, Persistent Negative Symptoms of Schizophrenia
Summary
|
|
EudraCT number |
2004-002560-17 |
Trial protocol |
FI DK SE DE CZ GB IT ES HU |
Global completion date |
02 Aug 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
06 Jun 2019
|
First version publication date |
02 Jun 2016
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
publicly available results synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.